Explore
placeholder image

Events

  • January 21, 2023

    Dr. Eric Morgen on the Talking Biotech podcast

    COO & co-founder Eric Morgen talks about aging as a risk for chronic disease, and BioAge’s approach to developing therapeutics that might slow or prevent age-related disorders.

    LinkedIn
  • January 4, 2023

    Virtual KOL event for apelin receptor agonist BGE-105

    BioAge leadership described target discovery by our AI-driven platform, clinical development, and the positive data from our Phase 1b trial, and two world-leading experts explained the clinical importance of muscle aging and the acute myopathies to be addressed in Phase 2.

    LinkedIn
  • November 17, 2022

    Investing in Longevity: CEO speaks at Longevity Week 2022

    At the “Investing in the Age of Longevity” event by Master Investor, CEO Kristen Fortney, delivered a talk about translating longevity science to create drugs that target diseases of aging.

    LinkedIn
  • November 12, 2022

    Kristen Fortney speaks at HLTH 2022

    At HTLH 2022 today, BioAge CEO Kristen Fortney joined the founders of Humanity Inc. to give an in-depth look at the longevity field.

    LinkedIn
Show more

© Copyright 2020-2023. All Rights Reserved

Address

1445A South 50th Street, Richmond, CA 94804

General info@bioagelabs.com (510) 806-1445
Media media@bioagelabs.com
Partnering partnering@bioagelabs.com
Address 1445A South 50th Street, Richmond, CA 94804

© Copyright 2020-2023. All Rights Reserved

General
info@bioagelabs.com (510) 806-1445
Media media@bioagelabs.com
Partnering partnering@bioagelabs.com

© Copyright 2020-2023. All Rights Reserved

Left gradient Right gradient
Address 1445A South 50th Street, Richmond, CA 94804

© Copyright 2020-2023. All Rights Reserved